Company: GANX
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001558370-25-003823
Chunk: 44

Company: Gain Therapeutics, Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 16
Chunk 44
---
ITEM 16. FORM 10-K SUMMARY

None.

​

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

​GAIN THERAPEUTICS, INC.​(Registrant)Date: March 27, 2025By:/s/ Gene Mack​​Gene Mack​​Chief Executive Officer ​​(Principal Executive Officer)​​​Date: March 27, 2025By:/s/ Gianluca Fuggetta​​Gianluca Fuggetta​​Senior Vice President Finance ​​(Principal Financial Officer and Principal Accounting Officer)

​

​